Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting Omalizumab Response in Asthma
NCT02023151Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2013
- Primary completion
- Jun 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of omalizumab in allergic asthma, sponsored by Johns Hopkins University. Started Feb 2013; status: completed.
02
Drugs
omalizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT02023151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023151.